An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA offered an accelerated approval path.

A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

Study identifies a novel mechanism driving osteosarcoma and provides insights to help predict patient outcomes. Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and ...

Scientists have described a novel, yet benign bone-covered growth's characteristics for doctors, so patients don't receive ...

Bone cancer in the leg, while relatively uncommon, presents with specific warning signs that warrant immediate medical attention. Understanding these symptoms enables individuals to seek prompt ...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer. The Royal Orthopaedic Hospital has secured a £110,000 grant from Orthopaedic Research UK to ...